Overview

Perioperative Chemotherapy Plus Toripalimab for dMMR Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

Status:
Not yet recruiting

Trial end date:
2029-02-28

Target enrollment:

Participant gender:

Summary

This study is a prospective, multi-center, randomized controlled phase II trial to compare the efficacy of perioperative SOX plus toripalimab, toripalimab monotherapy with SOX regimen in participants with dMMR locally advanced gastric or esophagogastric junction adenocarcinoma

Phase:

Phase 2

Details

Lead Sponsor:

Yu jiren

Treatments:

Oxaliplatin